Access cutting-edge solid tumors treatment through this clinical trial at a research site in Grand Rapids. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Grand Rapids location
Access solid tumors specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
Check if you qualify for this solid tumors clinical trial in Grand Rapids, MI
No-Cost Study Care
Local to Grand Rapids
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The study treatment, BAY 3713372, is under development to treat MTAP (methylthioadenosine phosphorylase)-deleted solid tumors. It is thought to work by blocking the protein arginine N-methyltransferase 5 (PRMT5). This may kill the MTAP-deleted cancer cells while sparing the normal cells. The main objective of this first-in-human study is to learn how safe BAY 3713372 is, how the body processes it, and how well it works in people with MTAP-deleted solid tumors. For this, the researchers will st
Sponsor: Bayer
Yes, this clinical trial (NCT06914128) has an active research site in Grand Rapids, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for solid tumors treatment options in Grand Rapids, MI, this clinical trial (NCT06914128) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Grand Rapids research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all solid tumors clinical trials near you to find additional studies recruiting in your area.
See all advanced solid tumors clinical trials recruiting in Grand Rapids — not just this study.
Browse Advanced Solid Tumors Trials in Grand Rapids →